These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27568729)

  • 1. Cannabinoids and Psychosis.
    D'Souza DC; Radhakrishnan R; Sherif M; Cortes-Briones J; Cahill J; Gupta S; Skosnik PD; Ranganathan M
    Curr Pharm Des; 2016; 22(42):6380-6391. PubMed ID: 27568729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Cannabis Use on the Development of Psychotic Disorders.
    Wilkinson ST; Radhakrishnan R; D'Souza DC
    Curr Addict Rep; 2014 Jun; 1(2):115-128. PubMed ID: 25767748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
    Sewell RA; Skosnik PD; Garcia-Sosa I; Ranganathan M; D'Souza DC
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S15-30. PubMed ID: 20512267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and psychosis/schizophrenia: human studies.
    D'Souza DC; Sewell RA; Ranganathan M
    Eur Arch Psychiatry Clin Neurosci; 2009 Oct; 259(7):413-31. PubMed ID: 19609589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gone to Pot - A Review of the Association between Cannabis and Psychosis.
    Radhakrishnan R; Wilkinson ST; D'Souza DC
    Front Psychiatry; 2014; 5():54. PubMed ID: 24904437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
    Levine A; Clemenza K; Rynn M; Lieberman J
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):214-225. PubMed ID: 28219487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis.
    D'Souza DC; DiForti M; Ganesh S; George TP; Hall W; Hjorthøj C; Howes O; Keshavan M; Murray RM; Nguyen TB; Pearlson GD; Ranganathan M; Selloni A; Solowij N; Spinazzola E
    World J Biol Psychiatry; 2022 Dec; 23(10):719-742. PubMed ID: 35315315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways to psychosis in cannabis abuse.
    Shrivastava A; Johnston M; Terpstra K; Bureau Y
    Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):30-5. PubMed ID: 23491968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Laboratory Studies on Cannabinoids and Psychosis.
    Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
    Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis-associated psychosis: Neural substrate and clinical impact.
    Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
    Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Cannabis Use in People with Psychosis.
    Chesney E; Lawn W; McGuire P
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):49-58. PubMed ID: 37971872
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic dissection of the psychotomimetic effects of cannabinoid exposure.
    O'Tuathaigh CM; Gantois I; Waddington JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():33-40. PubMed ID: 24239593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
    Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
    Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.